Are prevention and compassion antagonic valúes?;¿son valores antagónicos la prevención y la compasión?

Medicina Clinica

Volumn 135, Issue 14, 2010, Pages 650-652

  Miralda, Gaietà Permanyer ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ROSUVASTATIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE SEVERITY; EDITORIAL; HEART INFARCTION; HUMAN; HYPERTENSION; RISK REDUCTION;

EID: 78149360419     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.11.026     Document Type: Article

References (29)

1. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto Jr AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-207.
2. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, et al. Randomized trials stopped early for benefit: A systematic review. JAMA. 2005;294:2203-9.
3. Montori VM, Permanyer-Miralda G, Ferreira-González I, Busse JW, Pacheco-Huergo V, Bryant D, et al. Validity of composite end points in clinical trials. BMJ. 2005;330:594-6.
4. Ferreira-González I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, Bryant DM, et al. Problems with use of composite end points in cardiovascular trials: Systematic review of randomised controlled trials BMJ. 2007;334:786.
5. Editorial. Rosuvastatin and the statin wars-the way to peace. Lancet 2004;364:1997-9.
6. Hastings Center. The goals of medicine: Setting new priorities. Hastings Cent Rep 1996;26:S1-S27.
7. Berlin I. The pursuit of the ideal. En: Berlin I, editor. The crooked timber of humanity. Londres: Fontana Press; 1990.
8. Gibbons RJ. Rosuvastatin in patients with elevated C-reactive protein. N Engl J Med. 2009;360:1032-8.
9. Pierard LA. Rosuvastatin in patients with elevated C-reactive protein. N Engl J Med. 2009;360:1040-2.
10. Yusuf S, Lonn E, Bosch J. Lipid lowering for primary prevention. Lancet. 2009;373:1152-5.
11. Starfield B, Hyde J, Gérvas J, Heath I. The concept of prevention: A good idea gone astray? J Epidemiol Community Health. 2008;62:580-3.
12. Tinetti ME, Bogardus Jr ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870-4.
13. Gérvas J, Starfield B, Heath I. Is clinical prevention better than cure? Lancet. 2008;372:1997-9.
14. Callahan D. Setting limits: Medical goals in an aging society. Washington: Georgetown University Press; 1995. (Ed. esp. Poner lĺmites. Madrid: Triacastela, 2004).
15. Callahan D. El bien individual y el bien común en bioéitica. Barcelona: Cuadernos de la Fundació Vĺctor Grĺfols i Lucas: 2009;17:23-4.
16. Callahan D.H. What price better health? Hazards of the research imperative. Berkely: University of California Press; 2003:85-113.
17. Cassell EJ. The nature of suffering and the goals o medecine. N Engl J Med. 1982;306:639-45.
18. Bayés R. Afrontando la vida, esperando la muerte. Madrid: Alianza Editorial; 2006.
19. Wilson EO. Consilience: The unity of knowledge. London: Little, Brown & Co.; 1998.
20. Califf RM, DeMets DL. Principles from clinical trials relevant to clinical practice: Part II. Circulation. 2002;106:1172-5.
21. Cassell EJ. Diagnosing suffering: A perspective. Ann Intern Med. 1999;131:531-4.
22. Chapman CR, Gavrin J. Suffering: The contribution of persistent pain. Lancet. 1999;353:2233-7.
23. Singer PA. Recent advances. Medical ethics BMJ. 2000;321:282-5.
24. Singer PA, Martin DK, Kelner M. Quality end-of-life care: Patients' perspectives. JAMA. 1999;281:163-8.
25. Quill TE, Byock IR, American College of Physicians-American Society of Internal Medicine. Responding to intractable terminal suffering: The role of terminal sedation and voluntary refusal of food and fluids. ACP-ASIM End-of- Life Care Consensus Panel. Ann Intern Med. 2000;132:408-14.
26. Relman AS. The new medical-industrial complex. N Engl J Med. 1980;303:963-70.
27. Tuan Y-F. Topophilia. A study of environmental perception, attitudes and values. Englewood Cliffs: Prentice-Hall Inc; 1974. (Ed. esp. Topofilia. Melusina: 2007).
28. Heath I. In defence of a National Sickness Service. BMJ. 2007;334:19.
29. Relman AS. The future of medical practice. Health Aff (Millwood). 1983;2:5-19.